Get started
UNIQURE N.V. COM EUR0.05UNIQURE N.V. COM EUR0.05UNIQURE N.V. COM EUR0.05

UNIQURE N.V. COM EUR0.05

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0EE0 chart


Full chart

0EE0 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪827.66 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.955 USD
Net income (FY)
‪−308.48 M‬ USD
Revenue (FY)
‪15.84 M‬ USD
Shares float
‪42.40 M‬
Beta (1Y)
1.29

Employees


Employees (FY)
480
Change (1Y)
−21 −4.19%
Revenue / Employee (1Y)
‪33.01 K‬ USD
Net income / Employee (1Y)
‪−642.66 K‬ USD

About uniQure N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Matthew C. Kapusta
Website
uniqure.com
Headquarters
Amsterdam
Founded
2012
ISIN
NL0010696654
FIGI
BBG00JVRN0J8
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0EE0 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0EE0 is 17.485 USD — it has increased by 18.42% in the past 24 hours. Watch UNIQURE N.V. COM EUR0.05 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange UNIQURE N.V. COM EUR0.05 stocks are traded under the ticker 0EE0.
0EE0 stock has risen by 16.72% compared to the previous week, the month change is a 206.75% rise, over the last year UNIQURE N.V. COM EUR0.05 has showed a 170.67% increase.
We've gathered analysts' opinions on UNIQURE N.V. COM EUR0.05 future price: according to them, 0EE0 price has a max estimate of 58.00 USD and a min estimate of 20.00 USD. Watch 0EE0 chart and read a more detailed UNIQURE N.V. COM EUR0.05 stock forecast: see what analysts think of UNIQURE N.V. COM EUR0.05 and suggest that you do with its stocks.
0EE0 reached its all-time high on Jun 21, 2019 with the price of 81.000 USD, and its all-time low was 3.745 USD and was reached on Jul 5, 2024. View more price dynamics on 0EE0 chart.
See other stocks reaching their highest and lowest prices.
0EE0 stock is 20.00% volatile and has beta coefficient of 1.29. Track UNIQURE N.V. COM EUR0.05 stock price on the chart and check out the list of the most volatile stocks — is UNIQURE N.V. COM EUR0.05 there?
Today UNIQURE N.V. COM EUR0.05 has the market capitalization of ‪827.66 M‬, it has increased by 13.73% over the last week.
Yes, you can track UNIQURE N.V. COM EUR0.05 financials in yearly and quarterly reports right on TradingView.
UNIQURE N.V. COM EUR0.05 is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
0EE0 earnings for the last quarter are −0.91 USD per share, whereas the estimation was −0.99 USD resulting in a 8.33% surprise. The estimated earnings for the next quarter are −0.65 USD per share. See more details about UNIQURE N.V. COM EUR0.05 earnings.
UNIQURE N.V. COM EUR0.05 revenue for the last quarter amounts to ‪2.29 M‬ USD, despite the estimated figure of ‪6.86 M‬ USD. In the next quarter, revenue is expected to reach ‪17.92 M‬ USD.
0EE0 net income for the last quarter is ‪−44.38 M‬ USD, while the quarter before that showed ‪−56.30 M‬ USD of net income which accounts for 21.17% change. Track more UNIQURE N.V. COM EUR0.05 financial stats to get the full picture.
No, 0EE0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 480.00 employees. See our rating of the largest employees — is UNIQURE N.V. COM EUR0.05 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIQURE N.V. COM EUR0.05 EBITDA is ‪−190.63 M‬ USD, and current EBITDA margin is ‪−1.64 K‬%. See more stats in UNIQURE N.V. COM EUR0.05 financial statements.
Like other stocks, 0EE0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIQURE N.V. COM EUR0.05 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNIQURE N.V. COM EUR0.05 technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNIQURE N.V. COM EUR0.05 stock shows the buy signal. See more of UNIQURE N.V. COM EUR0.05 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.